New GLP-1 vial? Check the concentration

A refill can come with new instructions

A new pharmacy, a different vial size or a label that looks unfamiliar is a reason to pause and check. Do not assume that your old syringe mark transfers to the new bottle, even if the medicine name and prescribed milligram dose seem unchanged.

FDA has documented errors involving compounded semaglutide concentrations, syringes and conversions between milligrams, milliliters and “units.” Some patients needed hospital care.¹ This is a medication-reconciliation task for your prescriber and dispensing pharmacist, not a test of whether you are good at arithmetic. Our injection guide covers preparing for the appointment and asking for a demonstration.

What needs to match

Have the old and new labels available. Ask the pharmacist to confirm the active ingredient, concentration, prescribed dose and volume, the exact syringe to use, and the directions that apply to this shipment. Also ask whether any other ingredient changed. A color or cap size is not a reliable identifier.

Milligrams describe an amount of medicine; milliliters describe liquid volume. Syringe markings do not by themselves identify the amount of semaglutide inside. FDA specifically warns that different compounded concentrations may be available, including from one compounder.¹ There is no universal “units” chart that can safely replace a product-specific explanation.

Ask the pharmacist to demonstrate with the actual syringe or to provide an appropriate illustrated instruction sheet. Then explain the instruction back in your own words. If the pharmacy and clinic give different answers, ask them to reconcile the directions directly. Keep the written correction with the current prescription rather than saving conflicting screenshots.

Storage and dates need another look, too

Confirm the shipping and storage directions for this formulation, the date to discard it after first puncture, and the printed beyond-use date. Do not borrow a brand pen's room-temperature allowance for a compounded vial. The storage guide explains why “it arrived warm” needs a pharmacy-specific response rather than a blanket answer.

If a package arrived damaged or with an unexplained temperature problem, photograph it and ask the dispensing pharmacy what to do before using it. A clinic's sales representative may not be the person qualified to assess the dispensed product. Ask for the pharmacist's name and a direct contact route.

When a dose may already be wrong

If you may have injected the wrong amount, seek medical advice promptly; do not wait for a routine refill message. Severe or persistent vomiting, significant abdominal pain, fainting or inability to keep fluids down warrant urgent assessment. FDA's overdose reports included serious illness.¹ Do not try to correct the situation by changing the next dose yourself.

The dehydration guide explains why ongoing vomiting and poor fluid intake deserve attention. Once the immediate problem is addressed, ask the clinic to document the error and replace confusing directions.

A pharmacy change can be clinically reasonable, but it should not be invisible to you. Before the next shipment, request notice of changes and ask who is responsible for teaching the new instructions. Read what compounded semaglutide is for the broader questions about the pharmacy and product.